Alexion Pharmaceuticals, Inc. (ALXN) Tops Q2 EPS by 5c; Raises FY Outlook
Tweet Send to a Friend
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) reported Q2 EPS of $0.73, $0.05 better than the analyst estimate of $0.68. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
